FDA approves leucovorin for rare genetic condition, but not for autism

CNN·Mar 10

✦ NabkaNews BriefAuto-summarized from multiple outlets · verify with the source

The FDA has approved leucovorin for a rare genetic disorder, with some reports indicating it causes autism-like symptoms. However, the FDA has not approved the drug as a treatment for autism, citing a lack of evidence. The specific nature of the approved use and the disorder it treats is described variably, with some outlets noting it is an ultra-rare condition.

Full coverage

FDA approves leucovorin as first drug for rare genetic disorder, after touting it as autism treatment

CNBC·Mar 10

FDA declines to approve drug touted by Trump as a treatment for autism

Scientific American·Mar 11

US FDA approves leucovorin for rare genetic disorder causing autism-like symptoms

Reuters·Mar 10

Leucovorin lacks evidence to use as autism treatment, FDA says

STAT·Mar 10

FDA approves leucovorin for ultrarare cerebral folate deficiency subset without clinical trial

Fierce Pharma·Mar 10

FDA approves leucovorin for rare disorder

NBC4 Washington·Mar 10

FDA OKs Leucovorin for Ultra-Rare Genetic Disorder but Not Autism

Medscape·Mar 10

FDA approves leucovorin for ultra-rare genetic disorder causing autism-like symptoms

The Detroit News·Mar 10

View original report at CNN ↗

Fetching the latest headlines…